S&U: Profits up 32%, impairments halved — and Advantage has 'got its va-va-voom back'

About this episode

Anthony Coombs discusses S&U's financial recovery and the renewed energy of its motor finance arm, Advantage.

S&U PLC (LSE:SUS) chairman Anthony Coombs joined Proactive's Stephen Gunnion to discuss a strong financial recovery, with group profits up 32% and impairment charges more than halved. Coombs said Advantage, the motor finance arm, has emerged from two years of regulatory scrutiny with renewed energy — lending volumes are up sharply, credit quality has improved, and as he put it, the business has "got its va-va-voom back." Meanwhile, Aspen Bridging delivered record profits of £8.8 million, helped by new longer-term lending products that allow borrowers to transition from short-term bridges into extended financing. Looking ahead, Coombs sees demand for affordable motor finance remaining resilient and expects the property market to recover in the second half of the year — macroeconomic headwinds notwithstanding. For more insights like this, visit Proactive’s YouTube channel, like this video, subscribe, and enable notifications so you never miss an update. #SUplc #AnthonyCoombs #FinancialResults #MotorFinance #BridgingLoans #AspenFinance #AdvantageFinance #UKFinance #Investing #StockMarket #EarningsReport #BusinessNews #FinanceGrowth #Lending #ProactiveInvestors

People in this episode

Host: Stephen Gunnion

Guest: Anthony Coombs

Topics covered

• financial recovery
• motor finance
• property market
• lending
• impairment charges
• business growth

Keywords

• S&U
• profits
• motor finance
• Advantage
• Aspen Bridging
• financial results
• lending volumes
• credit quality
• property market
• investing

Mentioned in this episode

Organizations: S&U PLC, Advantage, Aspen Bridging, Proactive

Places: UK

More episodes of Proactive - Interviews for investors

• Regan Capital CIO on bond market opportunities in a rising rate environment · June 12, 2026 · 6 min
• Light Science Technologies lifts capacity 50% with new SMT line and global client win · June 12, 2026 · 5 min
• Poolbeg Pharma launches POLB 001 TOPICAL trial to tackle CAR-T side effects · June 12, 2026 · 4 min
• Lumos Diagnostics expands FebriDx adoption across 100+ US healthcare sites with CLIA Waiver · June 11, 2026 · 8 min
• Flow Metals advances drill-ready Yukon gold project while expanding Copper exploration in B.C. · June 11, 2026 · 6 min
• Midstream energy sector positioned for growth as LNG and AI drive demand · June 11, 2026 · 7 min